Michelle L. O’Donoghue, MD, MPH; Stephen J. Nicholls, MBBS, PhD DISCLOSURES | December 13, 2024 Michelle L. O’Donoghue, MD, MPH: Hi. This is Dr Michelle O’Donoghue, reporting for Medscape. I’m here at the American Heart Association Scientific Sessions. It’s a very exciting meeting, but one of the interesting topics that we’re going to be talking about is lipoprotein(a) [Lp(a)] ....
Tag: <span>targeted drugs</span>
Post
How Targeted Drugs Can Vanquish a Virulent Leukemia
Randy Dotinga For patients with acute myeloid leukemia (AML), especially those who are older or have relapsed/refractory disease, standard chemotherapy treatments often fail to change their poor clinical trajectories. These days, however, a new era of targeted therapy is improving prognoses somewhat — and raising hopes that even bigger advancements are on the horizon. “We...